Cargando…
Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
PURPOSE: Buprenorphine transdermal system is increasingly prescribed in people with advanced dementia, but no clinical trial has investigated the safety and factors associated with discontinuation due to adverse events in this population. PATIENTS AND METHODS: One hundred sixty-two people with advan...
Autores principales: | Erdal, Ane, Flo, Elisabeth, Aarsland, Dag, Selbaek, Geir, Ballard, Clive, Slettebo, Dagrun D, Husebo, Bettina S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960239/ https://www.ncbi.nlm.nih.gov/pubmed/29805252 http://dx.doi.org/10.2147/CIA.S161052 |
Ejemplares similares
-
Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018) -
COSMOS—improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial
por: Husebo, Bettina S., et al.
Publicado: (2015) -
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011) -
Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011
por: Gulla, Christine, et al.
Publicado: (2016) -
Sleep and its Association With Pain and Depression in Nursing Home Patients With Advanced Dementia – a Cross-Sectional Study
por: Blytt, Kjersti Marie, et al.
Publicado: (2021)